Search
Returning search results with filters:
Remove filter for
Category: Health products
Remove filter for
Issue: New safety information
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 16 - 29 of 29 items.
Anticipated shortage of euthanasia products for animals
AlertHealth professional risk communication | 2022-03-10
Rapid antigen test kits and potential exposure to hazardous substances
AlertPublic advisory | 2022-02-24
BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion
AlertHealth professional risk communication | 2022-02-03
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
AlertHealth professional risk communication | 2022-01-17
XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
AlertHealth professional risk communication | 2022-01-12
Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
AlertHealth professional risk communication | 2022-01-07
COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine): New Formulation for Use in Children Aged 5 Years to Less Than 12 Years
AlertHealth professional risk communication | 2021-11-19
Importation of COVID-19 Vaccine Moderna with up to 15 Doses per Vial and English-only Vial and Carton Labels (US-Labelled Supply)
AlertHealth professional risk communication | 2021-06-14
Health Canada clarifies position on Platelet Rich Plasma treatments
AlertInformation update | 2019-07-26
Important Safety Information on Alaris Infusion Sets and Alaris 8100 Pump Module - Risk of Over-Infusion
AlertHealth professional risk communication | 2019-05-30
Talc - Potential Risk of Lung Effects and Ovarian Cancer
AlertHealth professional risk communication | 2018-12-05
Tromboject 1% and 3% (sodium tetradecyl sulfate) with Visible Particles - Update on the Use of Medical Grade Filters
AlertHealth professional risk communication | 2018-09-12
Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA
AlertInformation update | 2018-09-10